This work updated the SLR and meta-analysis on probiotics in chronic inflammatory rheumatism and found: (1) a non-significant decrease of DAS28-CRP, (2) a significant decrease of CRP levels with RA patients under probiotics, (3) the absence of efficacy in patients with SpA. This evidence concerns the gene CRP and rheumatoid arthritis.